Table 1.
Number of deaths averted in children treated with azithromycin compared with placebo overall and by age-group, and Boboye and Loga districts, Niger
| Age | Placebo | Azithromycin | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Deaths | Person-years | Mortality rate per 1,000 py (95% CI) | Deaths | Person-years | Mortality rate per 1,000 py (95% CI) | Incidence rate difference per 1,000 py (95% CI) | Number needed to treat to avert 1 death (95% CI) | Number of deaths averted (95% CI) | |
| 1–5 m | 244 | 5,152 | 47.4 (41.6 to 53.6) | 202 | 5,657 | 35.7 (31.0 to 40.9) | −11.7 (−19.4 to −3.9) | 85.5 (51.1 to 256.4) | 126 (43 to 209) |
| 1–11 m | 584 | 12,299 | 47.5 (43.7 to 51.4) | 488 | 13,563 | 36.0 (32.9 to 39.3) | −11.5 (−16.0 to −5.4) | 87.0 (62.5 to 185.2) | 297 (168 to 427) |
| 1–59 m | 1,888 | 68,769 | 27.5 (26.2 to 28.7) | 1,727 | 76,924 | 22.5 (21.4 to 23.5) | −5.0 (−6.6 to −3.4) | 200 (151.5 to 294.1) | 729 (492 to 966) |
m = month; py = person-years.